HI-Bio dishes on motivations for Biogen buyout, citing desire to move fast

Why did Human Immunology Biosciences get bought out less than five months after closing a $95 million Series B?

HI-Bio’s executives were highly confident in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study finds high rates of sugar, salt in rural children’s diets

A study of over 10,000 children in rural Pennsylvania revealed that a large proportion of children were fed foods that are high in sugar and

July 24, 2023

Exclusive partnership and million-dollar sales potential with Cannabis Club Association. – Biotech Investments

EQS-News: Cannovum Cannabis AG / Key word(s): Joint Venture/Alliance Cannovum Cannabis AG: Exclusive partnership and million-dollar sales potential with Cannabis Club Association. 07.08.2023 / 07:30

August 8, 2023

Mainz Biomed Announces Collaboration with Fugene Genetics in Israel – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 18.07.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.